NB-Biovilda 50 contains Vildagliptin 50 mg, a DPP-4 inhibitor used in the treatment of type 2 diabetes. Vildagliptin works by enhancing the activity of incretin hormones, which increase insulin secretion and decrease glucagon release in response to meals. This helps lower blood sugar levels and improve overall glycemic control. NB-Biovilda 50 is typically used alongside diet and exercise to help manage type 2 diabetes, reduce post-meal blood sugar spikes, and lower the risk of diabetes-related complications, such as cardiovascular disease.
Reviews
There are no reviews yet.